About
Science 37.

Science 37 is making the promise of virtual trials the new reality. We broke away from the traditional clinical research model because we wanted to deliver an experience built on human connection. When you simplify clinical research so that people can participate from the comfort of home, so much more is possible. People from all communities can play a role in research, be reached faster, and stay engaged, because it’s built around their lives.

Science 37

We make clinical research more human and accessible.
When you achieve that, the results are extraordinary.

Science 37 Leadership.

David Coman
David Coman
Chief Executive Officer
Chris Ceppi
Chris Ceppi
Chief Product Officer
Jonathan Cotliar
Jonathan Cotliar
Chief Medical Officer
Steve Geffon
Steve Geffon
Chief Commercial Officer
Mike Zaranek
Mike Zaranek
Chief Financial Officer
Laura Podolsky
Laura Podolsky
General Counsel
Adriana Centeno
Adriana Centeno
VP, Administration
Darcy Forman
Darcy Forman
VP, Clinical Operations

Science 37 Investors & Partners.

  • Amgen
  • Boehringer-Ingelheim
  • DXR
  • Genentech
  • Glynn Capital
  • GV
  • Janssen
  • Lux
  • Novartis
  • PPD
  • Redmile Group
  • Sanofi
  • UCB